JAK2 and myeloproliferative disorder: After accounting for potentially undiagnosed myeloproliferative diseases, the authors established that JAK2-mutant CHIP was highly associated with risk of VTE, whereas TET2-mutated CHIP was only modestly associated; DNMT3A-mutated CHIP, the most common genotype, was unassociated with increased VTE risk.